Cure Pharmaceutical Holding Corp. (CURR)
NASDAQ · Technology
Cure Pharmaceutical Holding Corp. Net Income 2023–2024
Cure Pharmaceutical Holding Corp. annual/quarterly net income history and growth rate from 2023 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cure Pharmaceutical Holding Corp. net income for the quarter ending March 31, 2025 was -4.7 M, a 54.02% increase year-over-year.
- Cure Pharmaceutical Holding Corp. net income for the twelve months ending March 31, 2025 was -16.5 M.
- Cure Pharmaceutical Holding Corp. annual net income for 2024 was -39.5 M, a 157.90% increase from 2023.
- Cure Pharmaceutical Holding Corp. annual net income for 2023 was -15.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cure Pharmaceutical Holding Corp. Net Income — FAQ
Cure Pharmaceutical Holding Corp. (CURR) net income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Cure Pharmaceutical Holding Corp.'s net income?
Cure Pharmaceutical Holding Corp. (CURR) reported net income of -$39M for fiscal 2024.
Where can I see CURR's net income history?
The chart and table above show Cure Pharmaceutical Holding Corp.'s net income by year and by quarter, including the growth rate.